Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp.

作者信息

Reeves D S, Bywater M J, Holt H A

出版信息

J Antimicrob Chemother. 1981 Dec;8 Suppl E:57-68. doi: 10.1093/jac/8.suppl_e.57.

DOI:10.1093/jac/8.suppl_e.57

PMID:6799483

Abstract

摘要

相似文献

Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:57-68. doi: 10.1093/jac/8.suppl_e.57.

In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamases.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:29-37. doi: 10.1093/jac/8.suppl_e.29.

In-vitro activity of monobactam, SQ 26,776, against Gram-negative bacteria.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:49-55. doi: 10.1093/jac/8.suppl_e.49.

In-vitro studies on SQ 26,776, a new monobactam antibiotic.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:81-8. doi: 10.1093/jac/8.suppl_e.81.

Antibacterial activity of a monocyclic beta-lactam SQ 26,776.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:111-22. doi: 10.1093/jac/8.suppl_e.111.

SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:39-47. doi: 10.1093/jac/8.suppl_e.39.

SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:103-10. doi: 10.1093/jac/8.suppl_e.103.

Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.

J Antimicrob Chemother. 1985 Jun;15 Suppl C:15-23. doi: 10.1093/jac/15.suppl_c.15.

In-vitro activity of the monobactam Ro 17-2301 against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa.

J Antimicrob Chemother. 1985 Oct;16(4):457-61. doi: 10.1093/jac/16.4.457.

Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.

J Antimicrob Chemother. 1985 Jun;15 Suppl C:119-32. doi: 10.1093/jac/15.suppl_c.119.

引用本文的文献

In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis.

Antimicrob Agents Chemother. 1984 Feb;25(2):279-80. doi: 10.1128/AAC.25.2.279.

In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients.

Antimicrob Agents Chemother. 1984 Feb;25(2):212-5. doi: 10.1128/AAC.25.2.212.

In vitro activity of ciprofloxacin, azthreonam and ceftazidime against Serratia marcescens and Pseudomonas aeruginosa.

Eur J Clin Microbiol. 1984 Aug;3(4):368-9. doi: 10.1007/BF01977498.

Evaluation of aztreonam in experimental bacterial meningitis and cerebritis.

Antimicrob Agents Chemother. 1983 Nov;24(5):682-8. doi: 10.1128/AAC.24.5.682.

Pharmacokinetics of aztreonam in patients with chronic renal failure.

Clin Pharmacokinet. 1985 Jan-Feb;10(1):91-100. doi: 10.2165/00003088-198510010-00005.

Antibacterial therapy in patients with malignancies.

Cancer Metastasis Rev. 1987;5(3):271-93. doi: 10.1007/BF00047001.

Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Drugs. 1986 Feb;31(2):96-130. doi: 10.2165/00003495-198631020-00002.

Comparison of the effects of aztreonam and tigemonam against Escherichia coli and Klebsiella pneumoniae in vitro and in vivo.

Antimicrob Agents Chemother. 1991 Mar;35(3):417-22. doi: 10.1128/AAC.35.3.417.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验